Related references
Note: Only part of the references are listed.Empirical Estimates of the Marginal Cost of Health Produced by a Healthcare System: Methodological Considerations from Country-Level Estimates
Laura C. Edney et al.
PHARMACOECONOMICS (2022)
Changes in productivity in healthcare services in the Kingdom of Saudi Arabia
Mohammed Khaled Al-Hanawi et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2022)
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach
Silvia Moler-Zapata et al.
APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2022)
Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia
Oscar Espinosa et al.
HEALTH POLICY AND PLANNING (2022)
Ideas About Resourcing Health Care in the United States: Can Economic Evaluation Achieve Meaningful Use?
William Padula et al.
ANNALS OF INTERNAL MEDICINE (2021)
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States
David J. Vanness et al.
ANNALS OF INTERNAL MEDICINE (2021)
Modifying NICE's Approach to Equity Weighting
Mike Paulden et al.
PHARMACOECONOMICS (2021)
A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain
Mac Ardy Junio Gloria et al.
VALUE IN HEALTH (2021)
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach
Wieslawa Dominika Wranik et al.
JOURNAL OF MEDICAL ECONOMICS (2021)
Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research
Jessica Ochalek et al.
CLINICAL THERAPEUTICS (2020)
Estimating a cost-effectiveness threshold for health care decision-making in South Africa
Ijeoma P. Edoka et al.
HEALTH POLICY AND PLANNING (2020)
Efficiency evaluation of public hospitals in Saudi Arabia: an application of data envelopment analysis
Ahmed D. Alatawi et al.
BMJ OPEN (2020)
Health technology assessment in Japan: a work in progress
Isao Kamae et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Health technology assessment with risk aversion in health
Darius N. Lakdawalla et al.
JOURNAL OF HEALTH ECONOMICS (2020)
Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach
Jessica Ochalek et al.
PHARMACOECONOMICS (2020)
The Privatization of Health Care System in Saudi Arabia
Redwanur Rahman
HEALTH SERVICES INSIGHTS (2020)
Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis
Shouki Bazarbashi et al.
PHARMACOECONOMICS-OPEN (2020)
Pharmaceutical pricing policy in Saudi Arabia: findings and implications
Allan A. Alrasheedy
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL (2020)
Model Averaging and Its Use in Economics
Mark F. J. Steel
JOURNAL OF ECONOMIC LITERATURE (2020)
Estimating the Marginal Productivity of the English National Health Service From 2003 to 2012
James Lomas et al.
VALUE IN HEALTH (2019)
The marginal benefits of healthcare spending in the Netherlands: Estimating cost-effectiveness thresholds using a translog production function
Niek Stadhouders et al.
HEALTH ECONOMICS (2019)
A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending
Pieter van Baal et al.
HEALTH ECONOMICS (2019)
Estimating the marginal cost of a life year in Sweden's public healthcare sector
Jonathan Siverskog et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2019)
Accounting for Timing when Assessing Health-Related Policies
Karl Claxton et al.
JOURNAL OF BENEFIT-COST ANALYSIS (2019)
Estimating a cost-effectiveness threshold for the Spanish NHS
Laura Vallejo-Torres et al.
HEALTH ECONOMICS (2018)
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System
Laura Catherine Edney et al.
PHARMACOECONOMICS (2018)
The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all-cause and disease specific models of mortality
Karl Claxton et al.
HEALTH ECONOMICS (2018)
Cost-Effectiveness Thresholds: the Past, the Present and the Future
Praveen Thokala et al.
PHARMACOECONOMICS (2018)
Health technology assessment in Saudi Arabia
Sinaa Al-Aqeel
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2018)
Relevance of barriers and facilitators in the use of health technology assessment in Colombia
Florian Dams et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
A NEW CONCEPTUAL MODEL OF THE COST-EFFECTIVENESS THRESHOLD
M. Paulden
VALUE IN HEALTH (2018)
The Income Elasticity of Global Values of a Statistical Life: Stated Preference Evidence
Clayton J. Masterman et al.
JOURNAL OF BENEFIT-COST ANALYSIS (2018)
Estimating health opportunity costs in low-income and middle-income countries: a novel approach and evidence from cross-country data
Jessica Ochalek et al.
BMJ GLOBAL HEALTH (2018)
Inference in the presence of redundant moment conditions and the impact of government health expenditure on health outcomes in England
Martyn Andrews et al.
ECONOMETRIC REVIEWS (2017)
Determinants of Change in the Cost-effectiveness Threshold
Mike Paulden et al.
MEDICAL DECISION MAKING (2017)
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions
Mark Sculpher et al.
VALUE IN HEALTH (2017)
On the Estimation of the Cost-Effectiveness Threshold: Why, What, How?
Laura Vallejo-Torres et al.
VALUE IN HEALTH (2016)
County-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research
Beth Woods et al.
VALUE IN HEALTH (2016)
Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold
Karl Claxton et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations
Sinaa A. AL Aqeel et al.
SAUDI PHARMACEUTICAL JOURNAL (2012)
State of health economic evaluation research in Saudi Arabia: a review
Sinaa A. Al-Aqeel
CLINICOECONOMICS AND OUTCOMES RESEARCH (2012)
Pharmacoeconomic Analysis in Saudi Arabia: An Overdue Agenda Item for Action
Abdulrazaq S. Al-Jazairi et al.
ANNALS OF SAUDI MEDICINE (2011)
Government health expenditures and health outcomes
Farasat A. S. Bokhari et al.
HEALTH ECONOMICS (2007)
Share Paper
